Pacira BioSciences (PCRX) EBT (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly EBT of $5.0 million for Q1 2026, down 42.59% year-over-year from $8.7 million in Q1 2025, and up 775.31% quarter-over-quarter from $571000.0 in Q4 2025.
Pacira BioSciences (PCRX) EBT (2010 - 2026) Analysis & Trends
Pacira BioSciences' EBT history runs 17 years deep, the most recent figure standing at $5.0 million for Q1 2026.
- In Q1 2026, EBT fell 42.59% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $13.2 million (up 119.35% YoY), while the FY2025 annual figure was $16.9 million, up 126.74% from the prior year.
- EBT for Q1 2026 stood at $5.0 million, up from $571000.0 in the prior quarter.
- The five-year high for EBT was $37.9 million in Q2 2023, with the low at -$138.9 million in Q3 2024.
- The 5-year median for EBT is $8.7 million (2025), against an average of $2.0 million.
- The sharpest annual moves came in 2023 and 2024: EBT jumped 702.37% in 2023, then plunged 936.43% in 2024.
- Pacira BioSciences' EBT stood at -$18.1 million in 2022, then surged by 286.63% to $33.7 million in 2023, then dropped by 24.3% to $25.5 million in 2024, then plunged by 97.76% to $571000.0 in 2025, then soared by 775.31% to $5.0 million in 2026.
- Business Quant data shows PCRX's EBT at $5.0 million in Q1 2026, $571000.0 in Q4 2025, and $9.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -455.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 372.70 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -64.00 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 162.20 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 56.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Pacira BioSciences | 943.93 Mn | 692.90 Mn | 148.24 Mn | 2.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.56 Mn |
| Mar 31, 2026 | 5.00 Mn |
| Dec 31, 2025 | 571,000.00 |
| Sep 30, 2025 | 9.52 Mn |
| Jun 30, 2025 | -1.93 Mn |
| Mar 31, 2025 | 8.71 Mn |
| Dec 31, 2024 | 25.53 Mn |
| Sep 30, 2024 | -138.86 Mn |
| Jun 30, 2024 | 36.58 Mn |
| Mar 31, 2024 | 13.64 Mn |
| Dec 31, 2023 | 33.72 Mn |
| Sep 30, 2023 | 16.60 Mn |
| Jun 30, 2023 | 37.85 Mn |
| Mar 31, 2023 | -26.47 Mn |
| Dec 31, 2022 | -18.07 Mn |
| Sep 30, 2022 | 2.07 Mn |
| Jun 30, 2022 | 22.01 Mn |
| Mar 31, 2022 | 7.29 Mn |
| Dec 31, 2021 | -6.20 Mn |
| Sep 30, 2021 | 24.23 Mn |